SCHEMBL4440222

SCHEMBL4440222

CN(Cc1cc2nc(Cl)nc(N3CCOCC3)c2s1)CC1CCN(C(=O)O)CC1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 19/20 0.46
MTOR P42345 5/20 0.46
PIK3R1 P27986 8/20 0.43
PIK3CD O00329 7/20 0.42
PIK3CB P42338 7/20 0.42
PIK3CG P48736 6/20 0.42
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1181585 0.89 PIK3CD (0.43) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL1181829 0.89 PIK3CA (0.49) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL4555586 0.82 PIK3CA (0.52) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL1284104 0.81 PIK3CA (0.44) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL10316564 0.81 PIK3CA (0.57) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL4067340 0.80 PIK3CA (0.46) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL1089137 0.80 PIK3CD (0.54) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL1863036 0.79 PIK3CA (0.67) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL4441845 0.79 PIK3CA (0.54) PIK3CAMTORPIK3R1PIK3CDPIK3CB
Hydrochloric Acid SCHEMBL189960 0.79 PIK3CA (0.43) PIK3CAMTORPIK3R1PIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114949-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2009-11-11 EP disclosed
WO-2008070740-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO disclosed